Skip to main content
Premium Trial:

Request an Annual Quote

Synthetic Genomics, Venter Institute Form Vaccines Firm

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic Genomics and the non-profit J. Craig Venter Institute today announced that they have formed a new company, called Synthetic Genomics Vaccines, focused on genomic-based vaccines.

The partners, both based in La Jolla, Calif., and co-founded by Craig Venter, said they will develop next-generation vaccines using JCVI's genomic sequencing and synthetic genomic research expertise.

They also announced today a three-year deal with Novartis to use synthetic genomics technologies to accelerate the production of influenza seed strains required for vaccine manufacturing. The collaboration is supported by an award from the US Biomedical Advanced Research and Development Authority, though the partners did not disclose the amount of the award.

Under the collaboration, Novartis and SGVI aim to develop a "bank" of synthetically constructed seed viruses ready to go into production as soon as WHO identifies the flu strains. They hope the technology will reduce vaccine production time by up to two months.

JCVI and Novartis have worked together over the past decade to apply genomics research findings to vaccine development. They said that the latest collaboration introduced the use of genomics in vaccine research, a technology called "reverse vaccinology."

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.